BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kim EY, Ahn HS, Lee MY, Yu J, Yeom J, Jeong H, Min H, Lee HJ, Kim K, Ahn YM. An Exploratory Pilot Study with Plasma Protein Signatures Associated with Response of Patients with Depression to Antidepressant Treatment for 10 Weeks. Biomedicines 2020;8:E455. [PMID: 33126421 DOI: 10.3390/biomedicines8110455] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Zheng Y, Zhang L, He S, Xie Z, Zhang J, Ge C, Sun G, Huang J, Li H. Integrated Module of Multidimensional Omics for Peripheral Biomarkers (iMORE) in patients with major depressive disorder: rationale and design of a prospective multicentre cohort study. BMJ Open 2022;12:e067447. [DOI: 10.1136/bmjopen-2022-067447] [Reference Citation Analysis]
2 Kim MJ, Lim SJ, Ko Y, Kwon HE, Jung JH, Kwon H, Go H, Park Y, Kim T, Jung M, Pack C, Kim YH, Kim K, Shin S. Urinary Exosomal Cystatin C and Lipopolysaccharide Binding Protein as Biomarkers for Antibody−Mediated Rejection after Kidney Transplantation. Biomedicines 2022;10:2346. [DOI: 10.3390/biomedicines10102346] [Reference Citation Analysis]
3 Yang Y, Zhang Q, Yang J, Wang Y, Zhuang K, Zhao C. Possible Association of Nucleobindin-1 Protein with Depressive Disorder in Patients with HIV Infection. Brain Sciences 2022;12:1151. [DOI: 10.3390/brainsci12091151] [Reference Citation Analysis]
4 Yang Y, Zhang Q, Yang J, Wang Y, Zhuang K, Zhao C. Possible association of nucleobindin-1 protein with depressive disorder in patients with HIV infection.. [DOI: 10.1101/2022.07.08.22277410] [Reference Citation Analysis]
5 Ahn HS, Ho JY, Yu J, Yeom J, Lee S, Hur SY, Jung Y, Kim K, Choi YJ. Plasma Protein Biomarkers Associated with Higher Ovarian Cancer Risk in BRCA1/2 Carriers. Cancers (Basel) 2021;13:2300. [PMID: 34064977 DOI: 10.3390/cancers13102300] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
6 Tanaka M, Vécsei L. Editorial of Special Issue "Crosstalk between Depression, Anxiety, and Dementia: Comorbidity in Behavioral Neurology and Neuropsychiatry". Biomedicines 2021;9:517. [PMID: 34066395 DOI: 10.3390/biomedicines9050517] [Cited by in Crossref: 32] [Cited by in F6Publishing: 33] [Article Influence: 16.0] [Reference Citation Analysis]
7 Balogh L, Tanaka M, Török N, Vécsei L, Taguchi S. Crosstalk between Existential Phenomenological Psychotherapy and Neurological Sciences in Mood and Anxiety Disorders. Biomedicines 2021;9:340. [PMID: 33801765 DOI: 10.3390/biomedicines9040340] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 9.5] [Reference Citation Analysis]
8 Török N, Tanaka M, Vécsei L. Searching for Peripheral Biomarkers in Neurodegenerative Diseases: The Tryptophan-Kynurenine Metabolic Pathway. Int J Mol Sci 2020;21:E9338. [PMID: 33302404 DOI: 10.3390/ijms21249338] [Cited by in Crossref: 54] [Cited by in F6Publishing: 59] [Article Influence: 18.0] [Reference Citation Analysis]